Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Basic Research in Cardiology|August 18, 2012
Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilationK Hoetzenecker, A Assinger, M Lichtenauer, et al.
Annals of Surgical Oncology|August 14, 2025
Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable CholangiocarcinomaYawen Dong, Vanja Podrascanin, Zhihao Li, et al.
Annals of Surgical Oncology|August 5, 2025
Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Borderline Resectable CCA: A Real-World Exploratory AnalysisYawen Dong, Jonas Santol, Vanja Podrascanin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 17, 2026
Perioperative and oncologic outcomes of vascular resection after neoadjuvant therapy in intrahepatic cholangiocarcinomaYawen Dong, David Pereyra, Zhihao Li, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2025
The overarching prognostic role of tumor progression prior to cytoreductive hepatectomy in NETLMVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
Annals of Surgical Oncology|February 6, 2024
Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic AdenocarcinomaAlessandro Fogliati, Andrea Zironda, Guido Fiorentini, et al.
JCI Insight|June 28, 2022
SHP2 inhibition enhances Yes-associated protein-mediated liver regeneration in murine partial hepatectomy modelsRyan D Watkins, EeeLN H Buckarma, Jennifer L Tomlinson, et al.
Hepatology (Baltimore, Md.)|July 7, 2025
Liver resection with and without vascular resection versus transplantation for de novo perihilar cholangiocarcinomaYawen Dong, Zhihao Li, Vanja Podrascanin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancerYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2025
Preoperative von Willebrand factor is an independent predictive biomarker for post-hepatectomy liver failure-A multivariable model with APRI+ALBIYawen Dong, Lindsey A Gregory, Vanja Podrascanin, et al.
Pageof 9